State Street’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
1,006,893
+599,368
| +147% | +$851K | ﹤0.01% | 3409 |
|
|
2025
Q1 | $624K | Buy |
407,525
+88,250
| +28% | +$135K | ﹤0.01% | 3541 |
|
|
2024
Q4 | $792K | Buy |
319,275
+130,554
| +69% | +$324K | ﹤0.01% | 3534 |
|
|
2024
Q3 | $217K | Sell |
188,721
-7,900
| -4% | -$9.09K | ﹤0.01% | 3808 |
|
|
2024
Q2 | $216K | Sell |
196,621
-1,141,818
| -85% | -$1.26M | ﹤0.01% | 3799 |
|
|
2024
Q1 | $1.66M | Sell |
1,338,439
-50,000
| -4% | -$62K | ﹤0.01% | 3333 |
|
|
2023
Q4 | $1.46M | Sell |
1,388,439
-174,069
| -11% | -$183K | ﹤0.01% | 3398 |
|
|
2023
Q3 | $10.7M | Buy |
1,562,508
+110,524
| +8% | +$757K | ﹤0.01% | 2559 |
|
|
2023
Q2 | $15.1M | Buy |
1,451,984
+28,630
| +2% | +$297K | ﹤0.01% | 2415 |
|
|
2023
Q1 | $11.5M | Buy |
1,423,354
+120,024
| +9% | +$971K | ﹤0.01% | 2574 |
|
|
2022
Q4 | $20.5M | Buy |
1,303,330
+303
| +0% | +$4.77K | ﹤0.01% | 2228 |
|
|
2022
Q3 | $20.5M | Buy |
1,303,027
+72,786
| +6% | +$1.15M | ﹤0.01% | 2210 |
|
|
2022
Q2 | $17.2M | Buy |
1,230,241
+146,851
| +14% | +$2.05M | ﹤0.01% | 2360 |
|
|
2022
Q1 | $18.7M | Buy |
1,083,390
+36,000
| +3% | +$621K | ﹤0.01% | 2463 |
|
|
2021
Q4 | $15.2M | Sell |
1,047,390
-10,774
| -1% | -$157K | ﹤0.01% | 2660 |
|
|
2021
Q3 | $19M | Sell |
1,058,164
-12,050
| -1% | -$217K | ﹤0.01% | 2515 |
|
|
2021
Q2 | $18.8M | Buy |
1,070,214
+877,272
| +455% | +$15.4M | ﹤0.01% | 2558 |
|
|
2021
Q1 | $4.86M | Buy |
192,942
+114,902
| +147% | +$2.9M | ﹤0.01% | 3067 |
|
|
2020
Q4 | $505K | Hold |
78,040
| – | – | ﹤0.01% | 3644 |
|
|
2020
Q3 | $201K | Hold |
78,040
| – | – | ﹤0.01% | 3664 |
|
|
2020
Q2 | $126K | Sell |
78,040
-589,148
| -88% | -$951K | ﹤0.01% | 3645 |
|
|
2020
Q1 | $694K | Sell |
667,188
-70,210
| -10% | -$73K | ﹤0.01% | 3383 |
|
|
2019
Q4 | $1.39M | Sell |
737,398
-5,932
| -0.8% | -$11.2K | ﹤0.01% | 3351 |
|
|
2019
Q3 | $803K | Buy |
743,330
+136,751
| +23% | +$148K | ﹤0.01% | 3438 |
|
|
2019
Q2 | $1.33M | Sell |
606,579
-48,763
| -7% | -$107K | ﹤0.01% | 3369 |
|
|
2019
Q1 | $3.93M | Sell |
655,342
-79,341
| -11% | -$475K | ﹤0.01% | 2863 |
|
|
2018
Q4 | $5.43M | Buy |
734,683
+126,584
| +21% | +$935K | ﹤0.01% | 2676 |
|
|
2018
Q3 | $8.83M | Buy |
608,099
+51,454
| +9% | +$747K | ﹤0.01% | 2608 |
|
|
2018
Q2 | $11.1M | Sell |
556,645
-6,517
| -1% | -$130K | ﹤0.01% | 2488 |
|
|
2018
Q1 | $9.87M | Buy |
563,162
+73,738
| +15% | +$1.29M | ﹤0.01% | 2473 |
|
|
2017
Q4 | $12.1M | Sell |
489,424
-12,817
| -3% | -$316K | ﹤0.01% | 2373 |
|
|
2017
Q3 | $13M | Buy |
502,241
+171,486
| +52% | +$4.43M | ﹤0.01% | 2309 |
|
|
2017
Q2 | $8.97M | Buy |
330,755
+132,866
| +67% | +$3.6M | ﹤0.01% | 2451 |
|
|
2017
Q1 | $5.9M | Buy |
197,889
+27,259
| +16% | +$813K | ﹤0.01% | 2624 |
|
|
2016
Q4 | $4.63M | Buy |
170,630
+38,570
| +29% | +$1.05M | ﹤0.01% | 2731 |
|
|
2016
Q3 | $3.38M | Buy |
132,060
+12,050
| +10% | +$309K | ﹤0.01% | 2765 |
|
|
2016
Q2 | $2.22M | Buy |
120,010
+47,179
| +65% | +$872K | ﹤0.01% | 2993 |
|
|
2016
Q1 | $1.38M | Buy |
72,831
+28,178
| +63% | +$534K | ﹤0.01% | 3126 |
|
|
2015
Q4 | $1.2M | Buy |
+44,653
| New | +$1.2M | ﹤0.01% | 3177 |
|